Rapid Diagnostics Market to record USD 12.74 Bn | Evolving opportunities in North America | Technavio

Purchase our full report to get a detailed analysis of the market size, current and future growth opportunities, and other important statistics.
Download a Free Sample Report Before Purchasing

The market is driven by the increasing incidence of chronic and infectious diseases. In addition, the growing presence of OEMs is anticipated to boost the growth of the rapid diagnostics market.

The growth in the disposable incomes of middle-class consumers coupled with urbanization has resulted in an increase in the adoption of unhealthy lifestyles such as lack of exercise, poor eating habits, and addiction to alcohol and tobacco. This has increased the incidence of various chronic diseases such as heart diseases, diabetes, stroke, cancers, obesity, and kidney diseases across the world. For instance, according to a study, in 2020, nearly 88 million individuals in the US had one or more chronic health conditions, and one in four adults in the US suffer from two or more chronic diseases. The growing incidence of various chronic diseases is increasing the demand for diagnostic procedures such as rapid diagnostics and technologically advanced treatment options. All these factors are positively influencing the growth of the market in focus.

Get highlights on other major factors influencing the market growth. Download a Free Sample Report Now

Major Companies in the Rapid Diagnostics Market:

Abbott Laboratories: The company offers rapid diagnostics that provide fast, accurate, and reliable test results is vital in emergency rooms, critical care centers, and other situations where treatment decisions need to be made quickly.

Atomo Diagnostics Ltd.: The company offers rapid diagnostics that simplify procedures, mitigate common user errors, and enhance test performance used in is used in COVID-19 tests, HIV 1 and 2 tests, pregnancy tests, and respiratory tests.

Becton Dickinson and Co.: The company offers rapid diagnostics that are used to test sterile and non-sterile pharmaceuticals and medical devices, diagnose infectious diseases, screen for microbial presence, grow and identify organisms, and test for antibiotic susceptibility.

bioMerieux SA: The company offers rapid diagnostics that are used in infectious diseases, COVID-19, antimicrobial resistance and healthcare-associated infections, and cardiovascular emergencies.

Cardinal Health Inc.: The company offers rapid diagnostics that include respiratory testing solutions, color mono latex test kits, Crypto Giardia rapid test, h. Pylori blood antibody rapid test, and Mono II rapid test.

Identify other dominant players in the market. Request a Free Sample Report

Rapid Diagnostics Market: Segmentation Analysis

The global rapid diagnostics market is segmented by application (blood glucose, infectious disease, cardiometabolic, pregnancy and fertility, and others) and geography (North America, Europe, Asia, and Rest of the World (ROW)).

Rapid Diagnostics Market Application Outlook (Revenue, USD Billion, 2021-2026)

• Blood glucose - size and forecast 2021-2026
• Infectious disease - size and forecast 2021-2026
• Cardiometabolic - size and forecast 2021-2026
• Pregnancy and fertility - size and forecast 2021-2026
• Others - size and forecast 2021-2026

The blood glucose segment generated maximum revenue in the market in 2021. The segment is driven by the increasing prevalence of diabetes cases in both the younger (16-44 years) and older population (50-75 years). The market growth in the segment will be significant during the forecast period.

Rapid Diagnostics Market Geography Outlook (Revenue, USD Billion, 2021-2026)

• North America - size and forecast 2021-2026
• Europe - size and forecast 2021-2026
• Asia - size and forecast 2021-2026
• Rest of World (ROW) - size and forecast 2021-2026

North America accounted for the largest share of the market in 2021 and will continue to remain as the largest market for rapid diagnostics over the forecast period. Governments in the region are taking initiatives to create awareness about the importance of early diagnostics for various chronic diseases. This is increasing the adoption of rapid diagnostics products among healthcare providers, which is driving the growth of the regional market.

Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Request a Free Sample Report

Related Reports:

Arbovirus Testing Market by End-user and Geography - Forecast and Analysis 2022-2026

Automated Analyzers Market by Type and Geography - Forecast and Analysis 2022-2026

Table of Contents:

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application

• 5.3 Blood glucose - Market size and forecast 2021-2026
• Exhibit 28: Chart on Blood glucose - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Blood glucose - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Blood glucose - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Blood glucose - Year-over-year growth 2021-2026 (%)

• 5.4 Infectious disease - Market size and forecast 2021-2026
• Exhibit 32: Chart on Infectious disease - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Infectious disease - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Infectious disease - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Infectious disease - Year-over-year growth 2021-2026 (%)

• 5.5 Cardiometabolic - Market size and forecast 2021-2026
• Exhibit 36: Chart on Cardiometabolic - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Cardiometabolic - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Cardiometabolic - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Cardiometabolic - Year-over-year growth 2021-2026 (%)

• 5.6 Pregnancy and fertility - Market size and forecast 2021-2026
• Exhibit 40: Chart on Pregnancy and fertility - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Pregnancy and fertility - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Pregnancy and fertility - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Pregnancy and fertility - Year-over-year growth 2021-2026 (%)

• 5.7 Others - Market size and forecast 2021-2026
• Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.8 Market opportunity by Application
• Exhibit 48: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 50: Chart on Market share by geography 2021-2026 (%)
• Exhibit 51: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 52: Chart on Geographic comparison
• Exhibit 53: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.9 Japan - Market size and forecast 2021-2026
• Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.10 Germany - Market size and forecast 2021-2026
• Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.11 China - Market size and forecast 2021-2026
• Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.12 France - Market size and forecast 2021-2026
• Exhibit 90: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 91: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 92: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 93: Data Table on France - Year-over-year growth 2021-2026 (%)

• 7.13 Market opportunity by geography
• Exhibit 94: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 95: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 96: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 97: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 98: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 99: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 100: Matrix on vendor position and classification

• 10.3 Abbott Laboratories
• Exhibit 101: Abbott Laboratories - Overview
• Exhibit 102: Abbott Laboratories - Business segments
• Exhibit 103: Abbott Laboratories - Key news
• Exhibit 104: Abbott Laboratories - Key offerings
• Exhibit 105: Abbott Laboratories - Segment focus

• 10.4 Atomo Diagnostics Ltd.
• Exhibit 106: Atomo Diagnostics Ltd. - Overview
• Exhibit 107: Atomo Diagnostics Ltd. - Product / Service
• Exhibit 108: Atomo Diagnostics Ltd. - Key offerings

• 10.5 Becton Dickinson and Co.
• Exhibit 109: Becton Dickinson and Co. - Overview
• Exhibit 110: Becton Dickinson and Co. - Business segments
• Exhibit 111: Becton Dickinson and Co. - Key news
• Exhibit 112: Becton Dickinson and Co. - Key offerings
• Exhibit 113: Becton Dickinson and Co. - Segment focus

• 10.6 bioMerieux SA
• Exhibit 114: bioMerieux SA - Overview
• Exhibit 115: bioMerieux SA - Business segments
• Exhibit 116: bioMerieux SA - Key offerings
• Exhibit 117: bioMerieux SA - Segment focus

• 10.7 Cardinal Health Inc.
• Exhibit 118: Cardinal Health Inc. - Overview
• Exhibit 119: Cardinal Health Inc. - Business segments
• Exhibit 120: Cardinal Health Inc. - Key news
• Exhibit 121: Cardinal Health Inc. - Key offerings
• Exhibit 122: Cardinal Health Inc. - Segment focus

• 10.8 Chembio Diagnostics Inc.
• Exhibit 123: Chembio Diagnostics Inc. - Overview
• Exhibit 124: Chembio Diagnostics Inc. - Product / Service
• Exhibit 125: Chembio Diagnostics Inc. - Key offerings

• 10.9 Danaher Corp.
• Exhibit 126: Danaher Corp. - Overview
• Exhibit 127: Danaher Corp. - Business segments
• Exhibit 128: Danaher Corp. - Key news
• Exhibit 129: Danaher Corp. - Key offerings
• Exhibit 130: Danaher Corp. - Segment focus

• 10.10 F. Hoffmann La Roche Ltd.
• Exhibit 131: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 132: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 133: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 134: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 135: F. Hoffmann La Roche Ltd. - Segment focus

• 10.11 Johnson and Johnson
• Exhibit 136: Johnson and Johnson - Overview
• Exhibit 137: Johnson and Johnson - Business segments
• Exhibit 138: Johnson and Johnson - Key news
• Exhibit 139: Johnson and Johnson - Key offerings
• Exhibit 140: Johnson and Johnson - Segment focus

• 10.12 Siemens Healthineers AG
• Exhibit 141: Siemens Healthineers AG - Overview
• Exhibit 142: Siemens Healthineers AG - Business segments
• Exhibit 143: Siemens Healthineers AG - Key news
• Exhibit 144: Siemens Healthineers AG - Key offerings
• Exhibit 145: Siemens Healthineers AG - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 146: Inclusions checklist
• Exhibit 147: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 148: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 149: Research methodology
• Exhibit 150: Validation techniques employed for market sizing
• Exhibit 151: Information sources

• 11.5 List of abbreviations
• Exhibit 152: List of abbreviations

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio